Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.27B |
| 2 |
QXO
QXO Inc
QXO
|
+$1.14B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 4 |
Thermo Fisher Scientific
TMO
|
+$505M |
| 5 |
Walt Disney
DIS
|
+$502M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$938M |
| 3 |
Microsoft
MSFT
|
+$734M |
| 4 |
McDonald's
MCD
|
+$609M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$544M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.37% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2.43% |
| 4 | Financials | 2.27% |
| 5 | Industrials | 1.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENZ
11976
CALL
DELISTED
Enzo Biochem, Inc.
ENZ
| $37.1K | ﹤0.01% |
+34,000
| New | +$38.3K |
|
|
RYZ
11977
PUT
Ryerson Holding Corp
RYZ
$1.5B
| $37K | ﹤0.01% |
1,900
-1,600
| -46% | -$41.2K |
|
11978
CALL
Cumberland Pharmaceuticals
CPIX
$117M
| $37K | ﹤0.01% |
24,200
-13,900
| -36% | -$21.9K |
|
|
DX
11979
PUT
Dynex Capital
DX
$3.24B
| $37K | ﹤0.01% |
3,100
-15,300
| -83% | -$184K |
|
11980
PUT
Replimune Group
REPL
$1.4B
| $36.9K | ﹤0.01% |
4,100
-23,700
| -85% | -$165K |
|
|
APLT
11981
PUT
DELISTED
Applied Therapeutics
APLT
| $36.9K | ﹤0.01% |
7,900
+800
| +11% | +$3.79K |
|
|
SRTA
11982
CALL
Strata Critical Medical Inc
SRTA
$522M
| $36.9K | ﹤0.01% |
10,600
-17,100
| -62% | -$57K |
|
11983
PUT
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$11.9B
| $36.7K | ﹤0.01% |
+1,100
| New | +$37K |
|
11984
PUT
Digi International
DGII
$3.23B
| $36.7K | ﹤0.01% |
+1,600
| New | +$42.9K |
|
11985
My Size
MYSZ
$2M
| $36.7K | ﹤0.01% |
+1,762
| New | +$51.9K |
|
11986
PUT
Standard BioTools
LAB
$280M
| $36.6K | ﹤0.01% |
20,700
+20,300
| +5,075% | +$49.6K |
|
|
MGIC
11987
CALL
DELISTED
Magic Software Enterprises
MGIC
| $36.6K | ﹤0.01% |
3,800
-1,500
| -28% | -$16.9K |
|
|
XTLB
11988
XTL Biopharmaceuticals
XTLB
$6.84M
| $36.6K | ﹤0.01% |
3,859
+451
| +13% | +$4.62K |
|
|
AIM
11989
AIM ImmunoTech
AIM
$6.69M
| $36.5K | ﹤0.01% |
+981
| New | +$41.6K |
|
11990
CALL
Mistras Group
MG
$576M
| $36.5K | ﹤0.01% |
4,400
-3,800
| -46% | -$33.2K |
|
|
BMTX
11991
DELISTED
BM Technologies, Inc.
BMTX
| $36.3K | ﹤0.01% |
+16,152
| New | +$36.9K |
|
|
CAPT
11992
PUT
DELISTED
Captivision
CAPT
| $36.3K | ﹤0.01% |
+13,600
| New | +$61.6K |
|
11993
CALL
Angi Inc
ANGI
$191M
| $36.3K | ﹤0.01% |
1,890
+1,850
| +4,625% | +$40K |
|
11994
CALL
GraniteShares 2x Long TSLA Daily ETF
TSLR
$75.1M
| $36.3K | ﹤0.01% |
+2,600
| New | +$29.6K |
|
11995
PUT
Pediatrix Medical
MD
$2.16B
| $36.2K | ﹤0.01% |
4,800
+2,900
| +153% | +$24K |
|
11996
CALL
Rimini Street
RMNI
$466M
| $36.2K | ﹤0.01% |
11,800
+4,700
| +66% | +$12.9K |
|
11997
CALL
OraSure Technologies
OSUR
$265M
| $36.2K | ﹤0.01% |
8,500
-1,200
| -12% | -$6.1K |
|
|
LGVN
11998
Longeveron
LGVN
$23.6M
| $36.2K | ﹤0.01% |
+22,485
| New | +$39.3K |
|
11999
CALL
Pearson
PSO
$9.72B
| $36.2K | ﹤0.01% |
2,900
-1,600
| -36% | -$19.7K |
|
12000
CALL
TELA Bio
TELA
$28.9M
| $36.2K | ﹤0.01% |
7,700
+7,500
| +3,750% | +$39.5K |
|
Similar funds
Ken Griffin's Q2 2024 Portfolio in Review
As of Q2 2024, Ken Griffin held 15,899 positions worth $494B, down 4.7% from $518B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ken Griffin withdrew a net $42.4B in Q2 2024, closing 1,760 positions and reducing 6,731 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $1.46B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Carrier Global worth $140M.
- Ken Griffin's largest Q2 2024 buy was Carrier Global: 2,220,323 shares worth $140M.
- Ken Griffin added most to Invesco QQQ Trust in Q2 2024, an estimated $1.27B increase.
- Ken Griffin's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $938M.
- Ken Griffin fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $1.46B.
- Ken Griffin's ten largest holdings make up 29% of its $494B portfolio in Q2 2024.
- Ken Griffin opened 1,434 new positions and closed 1,760 in Q2 2024.
- Ken Griffin's portfolio value fell 4.7% quarter-over-quarter to $494B.
Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.